Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
Top Cited Papers
- 1 June 2011
- journal article
- practice guideline
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 21 (6), 593-646
- https://doi.org/10.1089/thy.2010.0417
Abstract
Background: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition. Methods: The development of these guidelines was commissioned by the American Thyroid Association in association with the American Association of Clinical Endocrinologists. The American Thyroid Association and American Association of Clinical Endocrinologists assembled a task force of expert clinicians who authored this report. The task force examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to develop the text and a series of specific recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group. Results: Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves' disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves' ophthalmopathy; and management of other miscellaneous causes of thyrotoxicosis. Conclusions: One hundred evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice.Keywords
This publication has 334 references indexed in Scilit:
- An Algorithm Informed by the Parathyroid Hormone Level Reduces Hypocalcemic Complications of ThyroidectomyWorld Journal of Surgery, 2010
- Thyroid Function Abnormalities and Cognitive Impairment in Elderly People: Results of the Invecchiare in Chianti StudyJournal of the American Geriatrics Society, 2008
- Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trialsCMAJ : Canadian Medical Association Journal, 2008
- Percutaneous Ethanol Injection of Hyperfunctioning Thyroid Nodules: Long-Term Follow-Up in 125 PatientsAmerican Journal of Roentgenology, 2008
- A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation SystemJournal of Clinical Endocrinology & Metabolism, 2008
- Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trialsBMJ, 2007
- Graves Disease in ChildhoodPediatric Drugs, 2003
- Effects of Propylthiouracil and Methimazole on Fetal Thyroid Status in Mothers with Graves' HyperthyroidismJournal of Clinical Endocrinology & Metabolism, 1997
- Predictors of Early Remission of Hyperthyroidism in ChildrenJournal of Clinical Endocrinology & Metabolism, 1997
- Congenital hypothyroidism in infant following maternal I131 therapy: With a review of bazards of environmental radioisotope contaminationThe Journal of Pediatrics, 1963